The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst ...

Bristol-Myers Squibb (BMY) wins FDA nod to expand the U.S. label for its blockbuster immunotherapy Opdivo in lung cancer.

Bristol Myers Squibb (BMY) closed at $54.20 in the latest trading session, marking a +0.82% move from the prior day. This change outpaced the S&P 500's 0.17% loss on the day. Meanwhile, the Dow lost 0 ...

On Wednesday, Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $53.76 which represents a slight increase of $0.86 or 1.63% from the prior close of $52.9. The stock opened at ...

AbbVie's acquisition of Cerevel Therapeutics strengthens its neuroscience pipeline with promising candidates, making ABBV a ...

Dividend investing can create substantial passive income over time. A conservative example illustrates this potential: ...

The Centers for Medicare & Medicaid Services (CMS) has added several changes to the Medicare price negotiation process ...

If we earn tomorrow’s dividend and then get assigned at expiration on October 25, we will earn $1.65 per share on $52.95 per ...

Pythons to highly venomous king browns, the course offered in the Northern Territory at TAFE seeks to prepare students for every kind of slithery encounter. A letter seen by the ABC shows the ...